CV-EMCrit – Cardiovascular Intensivist Series: Post Cardiopulmonary Bypass (CABG) Care with Trina Augustin
EMCrit Project
MAY 25, 2024
Management of the Post-CABG pt in the ICU EMCrit Project by Katrina Augustin.
EMCrit Project
MAY 25, 2024
Management of the Post-CABG pt in the ICU EMCrit Project by Katrina Augustin.
Drug Patent Watch
MAY 25, 2024
Annual Drug Patent Expirations for OXAYDO Oxaydo is a drug marketed by Zyla and is included in one NDA. It is available from one supplier.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaTech
MAY 25, 2024
The partnership aims to provide end-to-end development and manufacturing for biopharmaceutical drug substance and drug product.
EMCrit Project
MAY 25, 2024
Management of the Post-CABG pt in the ICU EMCrit Project by Katrina Augustin.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
PharmaTech
MAY 25, 2024
In an ASGCT Panel on nucleic acid- and cell-based vaccines in oncology, work on a personalized mRNA vaccine was highlighted.
Pharmacy Times
MAY 25, 2024
The findings demonstrated that daytime heat waves were associated with approximately 19% higher odds of asthma-related hospitalizations in children.
Express Pharma
MAY 25, 2024
India’s pharmaceutical industry is on a promising path, with a vision to reach a staggering $130 billion by 2030 and $450 billion by 2047, according to a report by Ernst and Young. This growth is fueled by a thriving pharma industry that has already exported over 300 million vaccine doses as of July 2023 and impressive growth with $668.9 million worth of medical devices shipped to the US alone in FY 2022-23.
Let's personalize your content